Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (201-210 of 400) with videos related to

Pageof 40
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2025
Radioligand treatment with [<sup>177</sup>Lu]Lu-PSMA I&T in elderly Patients - Safety, efficacy, and prognostic factors for survivalMarcel Schwinger, Charis Kalogirou, Vincent Scheper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinomaWiebke Schloetelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
SSTR-directed peptide receptor radionuclide therapy for recurrent meningiomas: analysis of safety, efficacy and prognostic factorsNatalie Hasenauer, Miriam Müller, Heribert Hänscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
[<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine NeoplasmsKerstin Michalski, Aleksander Kosmala, Philipp E Hartrampf, et al.
Nuklearmedizin. Nuclear Medicine|August 5, 2010
Splenic sclerosing haemangioma causes false-positive finding at FDG-PETA Al-Ibraheem, A K Buck, T Dechow, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
Improved cancer detection in Waldeyer's tonsillar ring by <sup>68</sup>Ga-FAPI PET/CT imagingS Serfling, Y Zhi, A Schirbel, et al.
Clinical and Translational Radiation Oncology|March 21, 2020
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaPhilipp E Hartrampf, Heribert Hänscheid, Olivia Kertels, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|April 1, 2017
CONTINUOUS INTRAVENOUS INFUSION ANESTHESIA WITH MEDETOMIDINE, KETAMINE, AND MIDAZOLAM AFTER INDUCTION WITH A COMBINATION OF ETORPHINE, MEDETOMIDINE, AND MIDAZOLAM OR WITH MEDETOMIDINE, KETAMINE, AND BUTORPHANOL IN IMPALA (AEPYCEROS MELAMPUS)Christina A Gerlach, Maya S Kummrow, Leith C Meyer, et al.
JACC. Cardiovascular Imaging|February 19, 2018
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [<sup>68</sup>Ga]Pentixafor-PET/CT in Correlation With Cardiac MRITheresa Reiter, Malte Kircher, Andreas Schirbel, et al.
Pageof 40

Showing results (201-210 of 400) with videos related to

Sort By:
Pageof 40
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2025
Radioligand treatment with [<sup>177</sup>Lu]Lu-PSMA I&T in elderly Patients - Safety, efficacy, and prognostic factors for survivalMarcel Schwinger, Charis Kalogirou, Vincent Scheper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinomaWiebke Schloetelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2025
SSTR-directed peptide receptor radionuclide therapy for recurrent meningiomas: analysis of safety, efficacy and prognostic factorsNatalie Hasenauer, Miriam Müller, Heribert Hänscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
[<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-04 Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine NeoplasmsKerstin Michalski, Aleksander Kosmala, Philipp E Hartrampf, et al.
Nuklearmedizin. Nuclear Medicine|August 5, 2010
Splenic sclerosing haemangioma causes false-positive finding at FDG-PETA Al-Ibraheem, A K Buck, T Dechow, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
Improved cancer detection in Waldeyer's tonsillar ring by <sup>68</sup>Ga-FAPI PET/CT imagingS Serfling, Y Zhi, A Schirbel, et al.
Clinical and Translational Radiation Oncology|March 21, 2020
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaPhilipp E Hartrampf, Heribert Hänscheid, Olivia Kertels, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|April 1, 2017
CONTINUOUS INTRAVENOUS INFUSION ANESTHESIA WITH MEDETOMIDINE, KETAMINE, AND MIDAZOLAM AFTER INDUCTION WITH A COMBINATION OF ETORPHINE, MEDETOMIDINE, AND MIDAZOLAM OR WITH MEDETOMIDINE, KETAMINE, AND BUTORPHANOL IN IMPALA (AEPYCEROS MELAMPUS)Christina A Gerlach, Maya S Kummrow, Leith C Meyer, et al.
JACC. Cardiovascular Imaging|February 19, 2018
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [<sup>68</sup>Ga]Pentixafor-PET/CT in Correlation With Cardiac MRITheresa Reiter, Malte Kircher, Andreas Schirbel, et al.
Pageof 40